Charm Therapeutics Receives Investment For Deep Learning-enabled Drug Discovery Research From Nvidia

CHARM Therapeutics, a 3D deep-learning biotechnology company, has announced an investment from NVentures, NVIDIA’s venture investment arm. This investment will enable CHARM to further develop novel medicines for oncology, utilizing advanced computing and machine learning to identify novel molecules through protein-ligand co-folding. The investment will also enable CHARM to continue to fund its rapidly growing organization while harnessing the power of NVIDIA’s accelerated computing platform.